Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
BeiGene
BeiGene
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Institutes of Health Clinical Center (CC)